SKAN Stock Overview
SKAN Group AG provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Asia, Europe, the Americas, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 4/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
SKAN Group AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CHF80.00 |
| 52 Week High | CHF88.60 |
| 52 Week Low | CHF62.70 |
| Beta | 0.86 |
| 1 Month Change | 10.34% |
| 3 Month Change | 1.65% |
| 1 Year Change | 16.79% |
| 3 Year Change | 515.38% |
| 5 Year Change | 912.66% |
| Change since IPO | 1,059.42% |
Recent News & Updates
Is There Now An Opportunity In SKAN Group AG (VTX:SKAN)?
Nov 22
A Look At The Fair Value Of SKAN Group AG (VTX:SKAN)
Sep 21Recent updates
Is There Now An Opportunity In SKAN Group AG (VTX:SKAN)?
Nov 22A Look At The Fair Value Of SKAN Group AG (VTX:SKAN)
Sep 21How Much Of BV Holding AG (BRN:BVHN) Do Insiders Own?
Mar 11Here's Why I Think BV Holding (BRN:BVHN) Is An Interesting Stock
Feb 04
Did You Participate In Any Of BV Holding's (BRN:BVHN) Fantastic 204% Return ?
Dec 31How Much Of BV Holding AG (BRN:BVHN) Do Insiders Own?
Dec 03Shareholder Returns
| SKAN | CH Life Sciences | CH Market | |
|---|---|---|---|
| 7D | 2.3% | -0.8% | 1.4% |
| 1Y | 16.8% | -22.3% | -1.1% |
Return vs Industry: SKAN exceeded the Swiss Life Sciences industry which returned -22.7% over the past year.
Return vs Market: SKAN exceeded the Swiss Market which returned -1.3% over the past year.
Price Volatility
| SKAN volatility | |
|---|---|
| SKAN Average Weekly Movement | 4.5% |
| Life Sciences Industry Average Movement | 4.6% |
| Market Average Movement | 3.5% |
| 10% most volatile stocks in CH Market | 7.1% |
| 10% least volatile stocks in CH Market | 1.6% |
Stable Share Price: SKAN is not significantly more volatile than the rest of Swiss stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: SKAN's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1968 | 1,269 | GL Huber | https://skan.com/de/home/ |
SKAN Group AG provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Asia, Europe, the Americas, and internationally. It operates in two segments: Equipment and Solutions (E&S) and Services and Consumables (S&C). The E&S segment offers mission-critical solutions for the pharmaceutical production, including isolators, integrated automated systems, and aseptic filling systems and solutions, as well as laboratory and cleanroom equipment.
SKAN Group AG Fundamentals Summary
| SKAN fundamental statistics | |
|---|---|
| Market Cap | CHF1.80b |
| Earnings (TTM) | CHF27.34m |
| Revenue (TTM) | CHF295.80m |
65.8x
P/E Ratio6.1x
P/S RatioIs SKAN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SKAN income statement (TTM) | |
|---|---|
| Revenue | CHF295.80m |
| Cost of Revenue | CHF79.11m |
| Gross Profit | CHF216.69m |
| Other Expenses | CHF189.35m |
| Earnings | CHF27.34m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
Mar 26, 2024
| Earnings per share (EPS) | 1.22 |
| Gross Margin | 73.26% |
| Net Profit Margin | 9.24% |
| Debt/Equity Ratio | 4.5% |
How did SKAN perform over the long term?
See historical performance and comparison